Nyxthracis (previously Obiltoxaximab SFL) Uniunea Europeană - română - EMA (European Medicines Agency)

nyxthracis (previously obiltoxaximab sfl)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - seruri imune și imunoglobuline, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.

Sonata România - română - myHealthbox

sonata

bayer ag - sc (suspensie concentrată) - 14,35 g/l bacillus pumilus tulpina qst 2808 (1 x 1012 cfu*/kg)*cfu reprezintă numărul de colonii (colony-forming unit)